A Minneapolis federal judge has overturned sanctions imposed last month on Boston Scientific in a whistleblower lawsuit lodged over two of its cardiac rhythm management devices. U.S. District Court Judge Joan Ericksen on Monday vacated the sanctions ordered Oct. 16 by the late Judge Steven Rau, according to a report by Law360. Rau had lambasted the […]
Whistleblower (qui tam) lawsuit
Boston Scientific can’t slip neurostim False Claims suit
A federal judge in New Jersey last week shot down a bid by Boston Scientific (NYSE:BSX) to dismiss a False Claims Act lawsuit brought over its Precision Plus neurostimulation device. The lawsuit, filed in March 2011 and unsealed in August 2012, alleges that Boston Scientific ran a scheme to defraud Medicare and promote off-label use of its […]
Appeals court tosses whistleblower suit against Biotronik
The plaintiff in a whistleblower lawsuit against Biotronik only gets one bite at the apple, a federal appeals court ruled last week in tossing the False Claims Act suit. The U.S. Court of Appeals for the Ninth Circuit upheld the dismissal of the second lawsuit brought by Max Bennett, a former Biotronik employee who alleged that the […]
Abbott whistleblower Colquitt loses appeal in off-label lawsuit
The whistleblower behind a decade-old lawsuit against Abbott (NYSE:ABT) lost his bid for a new trial after a federal appeals court this week denied his appeal. Former Guidant sales rep Kevin Colquitt sued Abbott, Johnson & Johnson (NYSE:JNJ) and Boston Scientific (NYSE:BSX) in 2006 for $219.4 million, claiming that they marketed the use of biliary stents to treat peripheral artery disease. (The magistrate overseeing the lawsuit, […]
Trial kicks off in 10-year-old Abbott stent case
A 10-year-old whistleblower lawsuit filed by a former Abbott (NYSE:ABT) sales rep, over the alleged off-label marketing of biliary stents, finally went to trial in Dallas yesterday. Plaintiff Kevin Colquitt, a former rep for Abbott’s Guidant division, sued Abbott, Johnson & Johnson (NYSE:JNJ) and Boston Scientific (NYSE:BSX) in 2006, claiming that they marketed the use of biliary stents to treat peripheral artery disease. (The magistrate overseeing […]
Ex-Unilife whistleblower backs down, apologizes, pays up to settle counter-suit
A former Unilife (NSDQ:UNIS) employee who accused the company and its management of misleading investors withdrew a whistleblower lawsuit, apologized for ever filing it and agreed to pay an unspecified amount to settle a counter-claim, the company said today. Talbot Smith, Unilife’s former vice president of integrated supply chain, accused the drug delivery device maker and its senior managers […]
Whistleblowing ex-Covidien rep sues for wrongful termination
A former sales rep for Covidien‘s vascular business accused the company of wrongful termination after it fired him for blowing the whistle to the FBI on an alleged kickbacks scheme.
Medtronic settles another whistleblower suit for $2.8m
Medtronic’s new Ev3 unit pays $1.3m in whistleblower suit
Biotronik settles kickbacks case for $5m
Federal prosecutors yesterday said Biotronik agreed to pony up $4.9 million, but admitted no wrongdoing, to settle allegations that it ran a kickbacks scheme to induce physicians to use its cardiac rhythm management devices.
Judge tosses FDA whistleblowers lawsuit
A federal judge last week tossed a lawsuit brought by 6 of the so-called "FDA 9" whistleblowers accusing the government of violating their constitutional rights with surveillance of their private email accounts.
